Consultation on Accounting Treatment of Common Stock Options: Discussion on Monthly Vesting and Journal Entries
A finance novice raised a question about the accounting treatment for the company issuing common shares (400,000 shares at $0.20 per share, par value $0.00001, vesting monthly at 11,000 shares from January 1, 2018). The proposed journal entry was: debit consulting expense $2,200, credit common stock $0.11 and additional paid-in capital $2,199.89. This article reorganizes the expression while retaining the details of the original question, and emphasizes that the treatment should be further confirmed based on the substance of the service agreement and accounting standards.
Hello, I am a finance professional who is not yet familiar with handling common stock/preferred stock options, and I hope to get some guidance from experienced accountants. Our company is currently facing the following situation, and I am unsure how to record the related transactions in the financial statements.
Background of the Issue
We plan to issue common stock to a shareholder named A, with the specific terms as follows:
- Share Class: Common Stock
- Quantity: 400,000 shares
- Price per Share: $0.20
- Vesting Schedule: 11,000 shares vest monthly starting January 1, 2018
- Par Value: $0.00001
My Initial Thoughts
I am considering preparing the journal entries as follows (using the monthly vesting of 11,000 shares as an example):
- Debit "Consulting Expense" account: $0.20 × 11,000 shares = $2,200
- Credit "Common Stock" account (at par value): $0.00001 × 11,000 shares = $0.11
- Credit "Common Stock - Additional Paid-In Capital" (APIC): $2,199.89
I think this approach is roughly correct, but I am not entirely sure. I would greatly appreciate any advice you can provide. Thank you!
Professional Tip
The above entry assumes that the share issuance is consideration for consulting services and that the services have been provided in accordance with the vesting schedule. For actual recording, you need to consider the specific service agreement, the fair value of the shares, and the vesting conditions, and follow applicable accounting standards (such as ASC 718 or IFRS 2) for judgment. It is recommended to consult a professional accountant or auditor to confirm the final treatment.